Jefferies Group's INDV Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 507,909 shares of Indivior Pharmaceuticals, Inc. (INDV) worth $15.48 M, representing 0.11% of the portfolio. First purchased in 2023-Q2, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in INDV, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 708,941 shares. Largest reduction occurred in Q3 2025, reducing 1.48 M shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Indivior Pharmaceuticals (INDV) Holding Value Over Time
Track share changes against reported price movement
Quarterly Indivior Pharmaceuticals (INDV) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,083 | Add 4.33% | 507,909 | $30.48 |
| Q4 2025 | -220,375 | Reduce 31.16% | 486,826 | $35.88 |
| Q3 2025 | -1.48 M | Reduce 67.71% | 707,201 | $24.11 |
| Q2 2025 | +708,941 | Add 47.86% | 2.19 M | $14.86 |
| Q1 2025 | -153,770 | Reduce 9.40% | 1.48 M | $9.39 |
| Q4 2024 | +625,673 | Add 61.98% | 1.64 M | $12.80 |
| Q3 2024 | -129,081 | Reduce 11.34% | 1.01 M | $9.85 |
| Q2 2024 | +419,843 | Add 58.42% | 1.14 M | $15.68 |
| Q1 2024 | -853,011 | Reduce 54.27% | 718,668 | $21.37 |
| Q4 2023 | +609,427 | Add 63.33% | 1.57 M | $15.11 |
| Q3 2023 | +375,711 | Add 64.06% | 962,252 | $21.74 |
| Q2 2023 | +586,541 | New Buy | 586,541 | $23.14 |
Jefferies Group's Indivior Pharmaceuticals Investment FAQs
Jefferies Group first purchased Indivior Pharmaceuticals, Inc. (INDV) in Q2 2023, acquiring 586,541 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Indivior Pharmaceuticals, Inc. (INDV) for 12 quarters since Q2 2023.
Jefferies Group's largest addition to Indivior Pharmaceuticals, Inc. (INDV) was in Q2 2025, adding 2,190,274 shares worth $32.54 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 507,909 shares of Indivior Pharmaceuticals, Inc. (INDV), valued at approximately $15.48 M.
As of the Q1 2026 filing, Indivior Pharmaceuticals, Inc. (INDV) represents approximately 0.11% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Indivior Pharmaceuticals, Inc. (INDV) was 2,190,274 shares, as reported at the end of Q2 2025.